ICD-10-CM Code R89.7

Abnormal histological findings in specimens from other organs, systems and tissues

Version 2020 Billable Code No Valid Principal Dx

Valid for Submission

R89.7 is a billable code used to specify a medical diagnosis of abnormal histological findings in specimens from other organs, systems and tissues. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code R89.7 might also be used to specify conditions or terms like 0-5 mitoses per 10 hpf , 1 or more mitotic figure per mm2, 10 or more mitotic figures per 10 high power field, 6-10 mitoses per 10 hpf , abnormal histology findings, adrenal surgical margin, involved by tumor, etc

According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.

ICD-10:R89.7
Short Description:Abnormal histolog findings in specimens from oth org/tiss
Long Description:Abnormal histological findings in specimens from other organs, systems and tissues

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R89.7 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • 0-5 mitoses per 10 HPF
  • 1 or more mitotic figure per mm2
  • 10 or more mitotic figures per 10 high power field
  • 6-10 mitoses per 10 HPF
  • Abnormal histology findings
  • Adrenal surgical margin, involved by tumor
  • Artifact
  • Artifact due to crushing
  • Artifact due to freezing
  • Artifact due to smearing
  • Benign glands at surgical margin
  • Biopsy result abnormal
  • Breast tubule formation finding
  • Breast tubule formation finding
  • Breast tubule formation finding
  • Breast tubule formation: Majority of tumor >75%
  • Breast tubule formation: Minimal <10%
  • Breast tubule formation: Moderate 10% to 75%
  • Cellular changes consistent with Cytomegalovirus
  • Deep
  • Deep radial periureteral soft tissue surgical margin, involved by tumor
  • Deep surgical margin involvement by tumor present
  • Deep surgical margin involvement by tumor present
  • Deep surgical margin involvement by tumor present
  • Deep surgical margin involvement by tumor present
  • Deep surgical margin involvement by tumor present
  • Deep surgical margin, focal, involvement by tumor present
  • Deep surgical margin, focal, involvement by tumor present
  • Deep surgical margin, multifocal, involvement by tumor present
  • Deep surgical margin, multifocal, involvement by tumor present
  • Distal ureteral surgical margin, involved by tumor
  • G3-4: Poorly differentiated/undifferentiated
  • Gerota's fascial surgical margin, involved by tumor
  • Greater than 10 mitoses per 10 HPF
  • Greater than 20 mitoses per 10 HPF
  • Greater than 4 mitoses per high power field
  • Gross pathology
  • Gross pathology - abnormality
  • Heart surgical margin, involved by tumor
  • Histological necrosis present after induction chemotherapy
  • Inferior lateral surgical margin, involvement by tumor present
  • Kidney, ureteral surgical margin, involved by tumor
  • Left lateral surgical margin, involvement by tumor present
  • Left parametrial surgical margin, involved by tumor
  • Less than 1 mitotic figure per mm2
  • Less than 10 mitoses per 10 HPF
  • Less than or equal to 4 mitoses per high power field
  • Microcalcifications present in specimen
  • Muscularis propria absent in specimen
  • Nonsurgical biopsy result abnormal
  • Pathology examination findings present
  • Pleura, great vessels surgical margin, involved by tumor
  • Proximal renal margin, partial nephrectomy only, involved by tumor
  • Proximal ureteral surgical margin, involved by tumor
  • Renal capsular surgical margin, involved by tumor
  • Renal pelvis surgical margin, involved by tumor
  • Renal pelvis surgical margin, involved by tumor
  • Renal pelvis surgical margin, involved by tumor
  • Renal pelvis surgical margin, involved by tumor
  • Renal pelvis, deep radial hilar surgical margin, involved by tumor
  • Renal pelvis, renal parenchymal surgical margin, involved by tumor
  • Renal pelvis, renal parenchymal surgical margin, involved by tumor
  • Renal vein surgical margin, involved by tumor
  • Renal vein surgical margin, involved by tumor
  • Right lateral surgical margin, involved by tumor
  • Right parametrial surgical margin, involved by tumor
  • Small vessel invasion by tumor present
  • Specimen involvement by macroscopic tumor present
  • Specimen involvement by matted nodes present
  • Specimen involvement by satellite nodule absent
  • Specimen involvement by satellite nodule present
  • Specimen obscured by inflammation
  • Specimen obscured by mucus
  • Specimen shows excessive cytolysis
  • Specimen with abnormal presence of endometrial cells
  • Superior lateral surgical margin, involved by tumor
  • Surgical anterior margin involved by malignant neoplasm
  • Surgical apical margin involved by malignant neoplasm
  • Surgical bile duct margin involved by carcinoma in situ
  • Surgical bile duct margin involved by malignant neoplasm
  • Surgical bile duct margin involved by malignant neoplasm
  • Surgical bladder neck margin involved by malignant neoplasm
  • Surgical bronchial margin involved by tumor
  • Surgical chest wall margin involved by malignant neoplasm
  • Surgical circumferential margin finding
  • Surgical circumferential margin involved by lymphoma
  • Surgical circumferential margin involved by malignant neoplasm
  • Surgical circumferential margin involved by malignant neoplasm
  • Surgical cystic duct margin involved by in situ carcinoma
  • Surgical cystic duct margin involved by malignant neoplasm
  • Surgical deep margin involved by ductal carcinoma in situ
  • Surgical deep margin involved by in situ carcinoma
  • Surgical deep margin involved by intraepithelial neoplasia
  • Surgical deep margin involved by malignant melanoma
  • Surgical deep margin involved by malignant neoplasm
  • Surgical deep margin involved by malignant neoplasm, focal
  • Surgical deep margin involved by malignant neoplasm, multifocal
  • Surgical distal bile duct margin involved by malignant neoplasm
  • Surgical distal margin involved by in situ carcinoma
  • Surgical distal margin involved by in situ carcinoma/adenoma
  • Surgical distal margin involved by lymphoma
  • Surgical distal margin involved by malignant neoplasm
  • Surgical distal margin involved by tumor
  • Surgical distal mucosal margin involved by in situ carcinoma
  • Surgical Gerota's fascial margin involved by malignant neoplasm
  • Surgical greater omental margin involved by malignant neoplasm
  • Surgical inferior margin involved by ductal carcinoma in situ
  • Surgical inferior margin involved by malignant neoplasm
  • Surgical inferior margin is closest uninvolved margin to malignant neoplasm
  • Surgical lateral margin involved by adenoma
  • Surgical lateral margin involved by in situ carcinoma
  • Surgical lateral margin involved by in situ carcinoma/adenoma
  • Surgical lateral margin involved by malignant neoplasm
  • Surgical lateral margin involved by ductal carcinoma in situ
  • Surgical lateral margin involved by in situ carcinoma
  • Surgical lateral margin involved by in situ melanoma
  • Surgical lateral margin involved by malignant melanoma
  • Surgical lateral margin involved by malignant neoplasm
  • Surgical lateral margin involved by tumor
  • Surgical lateral margin involved by tumor
  • Surgical lateral margin involved by tumor
  • Surgical lateral margin involved by tumor
  • Surgical lateral margin involved by tumor
  • Surgical margin involved by ductal carcinoma in situ
  • Surgical margin involved by ductal carcinoma in situ, extensive
  • Surgical margin involved by ductal carcinoma in situ, multifocal
  • Surgical margin involved by ductal carcinoma in situ, unifocal
  • Surgical margin involved by in situ carcinoma
  • Surgical margin involved by in situ carcinoma/adenoma
  • Surgical margin involved by intraepithelial neoplasia
  • Surgical margin involved by malignant neoplasm
  • Surgical margin involved by malignant neoplasm, extensive
  • Surgical margin involved by malignant neoplasm, multifocal
  • Surgical margin involved by malignant neoplasm, unifocal
  • Surgical margin involved by sarcoma
  • Surgical margin involvement by sarcoma cannot be assessed
  • Surgical margin involvement by tumor present
  • Surgical margin of optic nerve involved by tumor
  • Surgical margin of renal vessel involved by tumor
  • Surgical margin of renal vessel involved by tumor
  • Surgical margin of renal vessel involved by tumor
  • Surgical medial margin involved by ductal carcinoma in situ
  • Surgical medial margin involved by malignant neoplasm
  • Surgical mucosal margin involved by adenoma
  • Surgical mucosal margin involved by in situ carcinoma
  • Surgical mucosal margin involved by malignant neoplasm
  • Surgical omental margin finding
  • Surgical pancreatic duct margin involved by in situ carcinoma
  • Surgical pancreatic parenchymal margin involved by in situ carcinoma
  • Surgical parenchymal margin finding
  • Surgical parenchymal margin finding
  • Surgical parenchymal margin involved by malignant neoplasm
  • Surgical perinephric fat margin involved by malignant neoplasm
  • Surgical posterior margin involved by malignant neoplasm
  • Surgical posterolateral margin involved by malignant neoplasm
  • Surgical proximal bile duct margin involved by malignant neoplasm
  • Surgical proximal margin involved by adenoma
  • Surgical proximal margin involved by adenoma with high-grade dysplasia
  • Surgical proximal margin involved by adenoma with low-grade dysplasia
  • Surgical proximal margin involved by in situ carcinoma
  • Surgical proximal margin involved by in situ carcinoma/adenoma
  • Surgical proximal margin involved by lymphoma
  • Surgical proximal margin involved by malignant neoplasm
  • Surgical proximal mucosal margin involved by in situ carcinoma
  • Surgical renal capsular margin involved by malignant neoplasm
  • Surgical renal parenchymal margin involved by malignant neoplasm
  • Surgical renal vein margin involved by malignant neoplasm
  • Surgical superior margin involved by ductal carcinoma in situ
  • Surgical superior margin involved by malignant neoplasm
  • Surgical ureteral margin involved by malignant neoplasm
  • Surgical vascular margin involved by malignant neoplasm
  • Syphilis test finding
  • Thyroid surgical margin, involved by tumor
  • Treponema pallidum ELISA positive
  • Ureter, renal pelvis surgical margin, involved by tumor
  • Ureteral surgical margin, involved by tumor
  • Ureteral surgical margin, involved by tumor
  • Ureteral surgical margin, involved by tumor
  • Ureteral surgical margin, involved by tumor
  • Ureteral surgical margin, involved by tumor
  • Ureteral surgical margin, involved by tumor
  • Urinary bladder surgical margin, involved by tumor
  • Urinary bladder, deep radial surgical margin, involved by tumor
  • Urinary bladder, urachal surgical margin, involved by tumor
  • Urinary bladder, ureteral surgical margin, involved by tumor
  • Urinary bladder, urethral surgical margin, involved by tumor
  • Urinary bladder, uterine surgical margin, involved by tumor
  • Urinary bladder, vaginal surgical margin, involved by tumor

Convert R89.7 to ICD-9

  • 792.9 - Abn find-body subst NEC (Approximate Flag)
  • 795.4 - Abn histologic find NEC (Approximate Flag)

Code Classification

  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
    • Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
      • Abnormal findings in specimens from oth org/tiss (R89)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020